Effects of acute oxygen therapy on cognitive and driving performance in hypoxaemic COPD.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000249651

Acronym

DriveOx

Enrollment

Registered

2005-08-31

Start date

2004-07-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Cognitive function and driving performance on a computerised driving simulator are measured before and after intranasal oxygen at a flow rate known to relieve hypoxaemia. Duration of each intervention is approximately 40 minutes

Study design

Allocation

Randomised controlled trial

Intervention model

Crossover

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Clinical diagnosis of COPD, demonstrated hypoxaemia at rest on room air (PaO2<60mmHg) and demonstrated adequate reversal of hypoxaemia (to >60mmHg) with supplemental oxygen, current driving licence.

Exclusion criteria

No exclusion criteria

Outcome results